| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $19,233,017 ) (Continued on the next page) |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI168355 | Complement C5 inhibition as sepsis therapy | 000 | 3 | NIH | 1/22/2024 | $570,074 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI156724 | Disease and Race Specific Single-cell Epigenetic Mechanisms in Human SLE | 000 | 4 | NIH | 4/24/2024 | $807,048 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 000 | 4 | NIH | 1/30/2024 | $2,359,801 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG064951 | Does insulin sensitivity impact the potential of metformin to slow aging? | 000 | 5 | NIH | 2/22/2024 | $509,149 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL144605 | Protease-Mediated Vascular Instability in Development and Disease | 000 | 6 | NIH | 2/28/2024 | $760,030 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL145237 | Translational Control of Megakaryocyte and Platelet Gene Expression in Disease | 000 | 6 | NIH | 12/14/2023 | $641,012 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL131652 | Defining the Mechanisms of Lymphatic Vascular Growth and Function | 000 | 7 | NIH | 11/6/2023 | $486,131 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AR084235 | MuRF1 substrates and mechanisms of skeletal muscle atrophy | 000 | 1 | NIH | 3/27/2024 | $225,060 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R03AR083980 | The role of UBR5 in skeletal muscle atrophy and regrowth | 000 | 1 | NIH | 3/20/2024 | $170,500 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 000 | 1 | NIH | 3/29/2024 | $635,248 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 000 | 1 | NIH | 12/14/2023 | $426,250 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AR083823 | Deciphering the myofibroblast life cycle in skin wound healing | 001 | 1 | NIH | 3/6/2024 | $0 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AR083823 | Deciphering the myofibroblast life cycle in skin wound healing | 000 | 1 | NIH | 3/6/2024 | $72,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY034946 | Retinal Pigmented Epithelium Epigenome Dysregulation With Aging and Modulation by Diet | 000 | 1 | NIH | 2/21/2024 | $506,059 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 000 | 2 | NIH | 1/25/2024 | $476,629 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | U01AI176244 | Autoimmune Drivers and Protectors Team Science (ADAPTS) | 000 | 2 | NIH | 2/6/2024 | $1,159,263 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL167656 | Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV | 000 | 2 | NIH | 3/11/2024 | $593,804 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM149343 | Mechanisms of cohesin regulation in vertebrates | 001 | 2 | NIH | 3/28/2024 | $15,949 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM149343 | Mechanisms of cohesin regulation in vertebrates | 000 | 2 | NIH | 3/20/2024 | $383,625 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 001 | 2 | NIH | 2/8/2024 | $329,918 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R03AI175661 | Establishing a lineage tracing system for studying thymus-derived innate lymphoid cells | 000 | 2 | NIH | 2/20/2024 | $76,725 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE032911 | Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome | 000 | 2 | NIH | 1/19/2024 | $460,059 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL163095 | Novel lymphatic genes that regulate heart valve development and disease | 000 | 2 | NIH | 11/8/2023 | $487,160 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21DC020317 | Functional Analysis of GWAS loci associated with hearing loss. | 000 | 2 | NIH | 11/17/2023 | $191,813 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY033782 | Interrogating the intersection between diet and ocular autoimmunity | 000 | 3 | NIH | 4/9/2024 | $567,340 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $100,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $1,050,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $1,000,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $1,000,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 004 | 3 | NIH | 4/25/2024 | $1,460,414 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 3 | NIH | 3/25/2024 | $550,000 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM142726 | Research Supplements to Promote Diversity in Health-Related Research Mechanisms of APP ectodomain function | 002 | 4 | NIH | 3/28/2024 | $17,901 |
| | 2024 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 000 | 3 | NIH | 2/21/2024 | $547,403 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM142726 | Research Supplements to Promote Diversity in Health-Related Research Mechanisms of APP ectodomain function | 001 | 4 | NIH | 1/30/2024 | $220,211 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K01AR077684 | The role of Fbxl22 in the regulation of skeletal muscle mass | 001 | 3 | NIH | 4/18/2024 | $46,842 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01GM138889 | Centromere Interactions and Meiotic Chromosome Segregation in Yeast | 000 | 3 | NIH | 12/6/2023 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL153728 | Site-1 protease-mediated lipid metabolism in lymphatic vascular development | 000 | 4 | NIH | 10/24/2023 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE028001 | Sjogren's Syndrome Pathogenic Autoantibodies | 002 | 5 | NIH | 3/13/2024 | $386,930 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P30AR073750 | Oklahoma Rheumatic Disease Research Cores Center | 002 | 6 | NIH | 3/17/2024 | $276,047 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | U01AG055133 | MoTrPAC: UC Preclinical Animal Study Site | 002 | 7 | NIH | 2/7/2024 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DK085691 | Colon O-glycosylated mucus in the homeostasis of microbiota and host | 000 | 10 | NIH | 2/15/2024 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | CE152464 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/8/2023 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | CE152464 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | CE152517 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/8/2023 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | CE152517 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 12/19/2023 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | CE152517 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 000 | 1 | NIH | 11/30/2023 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 2 | NIH | 1/10/2024 | $0 |
| | 2024 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 2 | NIH | 1/10/2024 | $0 |
|
